Streetbeat News

Earnings

PCTI

PCTEL reported Q3 earnings per share (EPS) of $0.00, missing the estimate of $0.06. The company's sales also fell short of estimates, coming in at $17.39M instead of the expected $20.50M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:59 pm

RSLS

Reshape Lifesciences (NASDAQ:RSLS) is set to report its Q3 2023 sales, which are expected to be 2.155M.

Portfolio Pulse from totan@benzinga.com

November 08, 2023 | 9:59 pm

AQMS

Aqua Metals reported Q3 2023 GAAP EPS of $(0.04), beating the estimate of $(0.05) by 20%. However, the company's quarterly sales of $25.00K missed the estimate of $80.00K by 68.75%.

Portfolio Pulse from saritha@benzinga.com

November 08, 2023 | 9:58 pm

CUTR

Cutera's Q3 sales were reported at $46.50 million, missing the analyst consensus estimate of $52.70 million by 11.76 percent. This represents a 25.96 percent decrease compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:58 pm

RGNX

Regenxbio reported Q3 2023 GAAP EPS of $(1.41), beating the estimate of $(1.49) by 5.37%. This is a 19.43% increase over the same period last year. The company also reported sales of $28.91M, beating the estimate of $27.19M by 6.34%, a 9.06% increase from last year.

Portfolio Pulse from saritha@benzinga.com

November 08, 2023 | 9:57 pm

AE

Adams Resources & Energy (AMEX:AE) reported Q3 earnings of $0.88 per share, beating the analyst consensus estimate of $0.15 by 486.67%. However, this is a 16.98% decrease from the same period last year. The company also reported quarterly sales of $760.60 million, beating the analyst consensus estimate of $683.08 million by 11.35%, but this is a 10.82% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:56 pm

ETNB

89bio (NASDAQ:ETNB) reported Q3 losses of $(0.45) per share, beating the analyst consensus estimate of $(0.53) by 15.09 percent. This represents a 21.05 percent increase over losses of $(0.57) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:56 pm

INFN

Infinera has projected its Q3 2023 revenue to be between $378M and $392M, which is higher than the estimated $376.5M. The company also expects its adjusted EPS to be between $0.03 and $0.08, compared to the estimated $(0.01).

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:56 pm

ME

23andMe Holding (NASDAQ:ME) reported Q2 losses of $(0.16) per share, missing the analyst consensus estimate of $(0.14) by 14.29%. The company also reported quarterly sales of $50.00 million, missing the analyst consensus estimate of $56.80 million by 11.97%. This represents a 6.67% decrease in losses and a 33.92% decrease in sales compared to the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 08, 2023 | 9:55 pm

EQ

Equillium (NASDAQ:EQ) reported Q3 earnings per share of $(0.11), beating the analyst consensus estimate of $(0.21) by 47.62%. This is a 72.5% increase over losses from the same period last year. The company also reported quarterly sales of $8.87 million, beating the analyst consensus estimate of $8.00 million by 10.88%.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:55 pm